Showing 2251-2260 of 10580 results for "".
Dr. Matthias Donelan
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/scaarfx-donelan-/19250/Dr. Donelan has been treating patients with scarring following burns for more than 35 years. Although great progress has been made, he found it difficult to bring patients back to their pre-injury state. Learn about his experience with the Lumenis UltraPulse and how it has impacted patients' qualityImplementing and Growing PDT
https://practicaldermatology.com/series/pdt-in-practice/implementing-and-growing-pdt/29783/Dr. Todd Schlesinger described how he implemented photodynamic therapy in his practice and the strategies he utilized to increase patient access to it.A New Year and New Beginnings
https://practicaldermatology.com/series/the-practical-dermatology-podcast/a-new-year-and-new-beginnings/32417/The Practical Dermatology Podcast relaunches with the latest news to start 2025 and a conversation between Chief Medical Editor Neal Bhatia, MD, FAAD, and new Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD. Dr. Bhatia and Dr. Swanson discuss the new wave of atopic dermatitis therapeuticExperts React to Latest Benzene Analysis
https://practicaldermatology.com/series/dermwire-tv/experts-react-to-latest-benzene-analysis/29810/In this week's DermwireTV, Practical Dermatology Editorial Board members provide their thoughts on the recent analysis examining benzene concentrations in BPO products; Johnson & Johnson seeks new indications for IL-23 inhibitor Tremfya; and the founder and CEO of Terns discusses plans to improvPromising New Data on Clascoterone for Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/promising-new-data-on-clascoterone-for-androgenetic-alopecia/56939/Cosmo Pharmaceuticals CEO Giovanni Di Napoli discusses the challenges posed by androgenetic alopecia (AGA) and the potential impact of a clascoterone 5% topical solution based on new Phase 3 data.Balneotherapy Continued: A Future in US Dermatology?
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/balneotherapy-continued-a-future-in-us-dermatology/54116/Practical Dermatology editorial board member Peter Lio, MD, and Karan Lal, DO, MS, FAAD, continue their discussion of the International Journal of Biometeorology article “Balneotherapy using thermal mineral water baths and dermatological diseases: a systematic review,” covering the evidence supportiCommitment to Clinical Evidence in Regenerative Aesthetics
https://practicaldermatology.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/Laura Ellis, MD, CEO and Co-Founder of LevEllis, Inc., discusses the current state of aesthetic regenerative medicine and the importance of clinical evidence as the field continues to advance.The Future of Customized Treatments Within the Atopic Dermatitis Pipeline
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/the-future-of-customized-treatments-within-the-atopic-dermatitis-pipeline/37165/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, discusses the potential impact of new developments in atopic dermatitis research.Research Highlights Disparities in AD Care
https://practicaldermatology.com/programs/practical-dermatology/research-highlights-disparities-in-ad-care/36472/In this episode of DermwireTV, research on socioeconomic disparities in atopic dermatitis care; new information on guselkumab for scalp psoriasis in diverse skin tones; the impact of air quality on dermatitis; and a C-Suite Chat with Anastasia Georgievskaya, founder of Haut.AI.Noah Worcester 2024: Dr. Mesinkovska on Alopecia Areata
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-mesinkovska-alopecia-areata/24586/Natasha Atanaskova Mesinkovska. MD, PhD, summarizes her lecture on JAK inhibitors and minoxidil at the 2024 Noah Worcester Dermatological Society meeting.